Erasca
ERAS
89 hedge funds and large institutions have $428M invested in Erasca in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 10 closing their positions.
90% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 10
68% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 19
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
9% more funds holding
Funds holding: 82 → 89 (+7)
3.2% more ownership
Funds ownership: 59.9% → 63.1% (+3.2%)
32% less capital invested
Capital invested by funds: $627M → $428M (-$198M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$7.13M |
| 2 |
ROTUOC
Regents of the University of California
Oakland,
California
|
+$5.96M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$4.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.06M |
| 5 |
BlackRock
New York
|
+$2.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECG
Edge Capital Group
Atlanta,
Georgia
|
-$1.79M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$628K |
| 3 |
Walleye Capital
New York
|
-$569K |
| 4 |
D.E. Shaw & Co
New York
|
-$453K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$262K |
ERAS Hedge Fund Activity: Q2 2022 in Review
89 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Erasca (ERAS) for Q2 2022, worth a combined $428M — down 32% from $627M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ERAS positions and 10 closed out — a net gain of 9 holders — while 32 added to existing stakes and 19 trimmed.
The largest buyer was PFM Health Sciences, adding an estimated $7.13M. The largest seller was Edge Capital Group, exiting entirely with an estimated $1.79M sold.
- 89 institutional investors held Erasca (ERAS) as of Q2 2022, up from 82 in Q1 2022.
- Funds reported $428M of Erasca stock for Q2 2022, down 32% quarter-over-quarter.
- 19 funds opened new Erasca positions in Q2 2022 and 10 closed out, a net change of +9 holders.
- The largest Erasca buyer in Q2 2022 was PFM Health Sciences, an estimated $7.13M added.
- The largest Erasca seller in Q2 2022 was Edge Capital Group, an estimated $1.79M sold.
Based on aggregated 13F filings for Q2 2022.